Immune and Genetics Protocols, LLC – Trademark Portfolio

Entity Type: 16

Immune and Genetics Protocols, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include IMMUNE BIO GREENCELL IMMUNE SYSTEM SUPPORT and IMMUNE BIO GREEN CELL IMMUNE SYSTEM SUPPORT. The owner is based in Orlando, FL.

5701 Dogwood Drive

Orlando, FL 32807

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Immune and Genetics Protocols, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Immune and Genetics Protocols, LLC have?

Immune and Genetics Protocols, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.

What trademark classes does Immune and Genetics Protocols, LLC file in?

Immune and Genetics Protocols, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Immune and Genetics Protocols, LLC's most well-known trademarks?

Immune and Genetics Protocols, LLC's registered trademark portfolio includes well-known marks such as IMMUNE BIO GREENCELL IMMUNE SYSTEM SUPPORT and IMMUNE BIO GREEN CELL IMMUNE SYSTEM SUPPORT. These are among 2 currently registered trademarks in the portfolio.

What is Immune and Genetics Protocols, LLC's trademark registration success rate?

Immune and Genetics Protocols, LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.